Soumettre la recherche
Mettre en ligne
2. POLA KUMAN Agustus 2020 (1).docx
•
Télécharger en tant que DOCX, PDF
•
0 j'aime
•
3 vues
M
maspullamuruprint
Suivre
patologi klinik (pola kuman)
Lire moins
Lire la suite
Santé
Signaler
Partager
Signaler
Partager
1 sur 64
Télécharger maintenant
Recommandé
2024 State of Marketing Report – by Hubspot
2024 State of Marketing Report – by Hubspot
Marius Sescu
Everything You Need To Know About ChatGPT
Everything You Need To Know About ChatGPT
Expeed Software
Product Design Trends in 2024 | Teenage Engineerings
Product Design Trends in 2024 | Teenage Engineerings
Pixeldarts
How Race, Age and Gender Shape Attitudes Towards Mental Health
How Race, Age and Gender Shape Attitudes Towards Mental Health
ThinkNow
AI Trends in Creative Operations 2024 by Artwork Flow.pdf
AI Trends in Creative Operations 2024 by Artwork Flow.pdf
marketingartwork
Skeleton Culture Code
Skeleton Culture Code
Skeleton Technologies
PEPSICO Presentation to CAGNY Conference Feb 2024
PEPSICO Presentation to CAGNY Conference Feb 2024
Neil Kimberley
Content Methodology: A Best Practices Report (Webinar)
Content Methodology: A Best Practices Report (Webinar)
contently
Recommandé
2024 State of Marketing Report – by Hubspot
2024 State of Marketing Report – by Hubspot
Marius Sescu
Everything You Need To Know About ChatGPT
Everything You Need To Know About ChatGPT
Expeed Software
Product Design Trends in 2024 | Teenage Engineerings
Product Design Trends in 2024 | Teenage Engineerings
Pixeldarts
How Race, Age and Gender Shape Attitudes Towards Mental Health
How Race, Age and Gender Shape Attitudes Towards Mental Health
ThinkNow
AI Trends in Creative Operations 2024 by Artwork Flow.pdf
AI Trends in Creative Operations 2024 by Artwork Flow.pdf
marketingartwork
Skeleton Culture Code
Skeleton Culture Code
Skeleton Technologies
PEPSICO Presentation to CAGNY Conference Feb 2024
PEPSICO Presentation to CAGNY Conference Feb 2024
Neil Kimberley
Content Methodology: A Best Practices Report (Webinar)
Content Methodology: A Best Practices Report (Webinar)
contently
How to Prepare For a Successful Job Search for 2024
How to Prepare For a Successful Job Search for 2024
Albert Qian
Social Media Marketing Trends 2024 // The Global Indie Insights
Social Media Marketing Trends 2024 // The Global Indie Insights
Kurio // The Social Media Age(ncy)
Trends In Paid Search: Navigating The Digital Landscape In 2024
Trends In Paid Search: Navigating The Digital Landscape In 2024
Search Engine Journal
5 Public speaking tips from TED - Visualized summary
5 Public speaking tips from TED - Visualized summary
SpeakerHub
ChatGPT and the Future of Work - Clark Boyd
ChatGPT and the Future of Work - Clark Boyd
Clark Boyd
Getting into the tech field. what next
Getting into the tech field. what next
Tessa Mero
Google's Just Not That Into You: Understanding Core Updates & Search Intent
Google's Just Not That Into You: Understanding Core Updates & Search Intent
Lily Ray
How to have difficult conversations
How to have difficult conversations
Rajiv Jayarajah, MAppComm, ACC
Introduction to Data Science
Introduction to Data Science
Christy Abraham Joy
Time Management & Productivity - Best Practices
Time Management & Productivity - Best Practices
Vit Horky
The six step guide to practical project management
The six step guide to practical project management
MindGenius
Beginners Guide to TikTok for Search - Rachel Pearson - We are Tilt __ Bright...
Beginners Guide to TikTok for Search - Rachel Pearson - We are Tilt __ Bright...
RachelPearson36
Unlocking the Power of ChatGPT and AI in Testing - A Real-World Look, present...
Unlocking the Power of ChatGPT and AI in Testing - A Real-World Look, present...
Applitools
12 Ways to Increase Your Influence at Work
12 Ways to Increase Your Influence at Work
GetSmarter
ChatGPT webinar slides
ChatGPT webinar slides
Alireza Esmikhani
More than Just Lines on a Map: Best Practices for U.S Bike Routes
More than Just Lines on a Map: Best Practices for U.S Bike Routes
Project for Public Spaces & National Center for Biking and Walking
Ride the Storm: Navigating Through Unstable Periods / Katerina Rudko (Belka G...
Ride the Storm: Navigating Through Unstable Periods / Katerina Rudko (Belka G...
DevGAMM Conference
Barbie - Brand Strategy Presentation
Barbie - Brand Strategy Presentation
Erica Santiago
Good Stuff Happens in 1:1 Meetings: Why you need them and how to do them well
Good Stuff Happens in 1:1 Meetings: Why you need them and how to do them well
Saba Software
Introduction to C Programming Language
Introduction to C Programming Language
Simplilearn
Contenu connexe
En vedette
How to Prepare For a Successful Job Search for 2024
How to Prepare For a Successful Job Search for 2024
Albert Qian
Social Media Marketing Trends 2024 // The Global Indie Insights
Social Media Marketing Trends 2024 // The Global Indie Insights
Kurio // The Social Media Age(ncy)
Trends In Paid Search: Navigating The Digital Landscape In 2024
Trends In Paid Search: Navigating The Digital Landscape In 2024
Search Engine Journal
5 Public speaking tips from TED - Visualized summary
5 Public speaking tips from TED - Visualized summary
SpeakerHub
ChatGPT and the Future of Work - Clark Boyd
ChatGPT and the Future of Work - Clark Boyd
Clark Boyd
Getting into the tech field. what next
Getting into the tech field. what next
Tessa Mero
Google's Just Not That Into You: Understanding Core Updates & Search Intent
Google's Just Not That Into You: Understanding Core Updates & Search Intent
Lily Ray
How to have difficult conversations
How to have difficult conversations
Rajiv Jayarajah, MAppComm, ACC
Introduction to Data Science
Introduction to Data Science
Christy Abraham Joy
Time Management & Productivity - Best Practices
Time Management & Productivity - Best Practices
Vit Horky
The six step guide to practical project management
The six step guide to practical project management
MindGenius
Beginners Guide to TikTok for Search - Rachel Pearson - We are Tilt __ Bright...
Beginners Guide to TikTok for Search - Rachel Pearson - We are Tilt __ Bright...
RachelPearson36
Unlocking the Power of ChatGPT and AI in Testing - A Real-World Look, present...
Unlocking the Power of ChatGPT and AI in Testing - A Real-World Look, present...
Applitools
12 Ways to Increase Your Influence at Work
12 Ways to Increase Your Influence at Work
GetSmarter
ChatGPT webinar slides
ChatGPT webinar slides
Alireza Esmikhani
More than Just Lines on a Map: Best Practices for U.S Bike Routes
More than Just Lines on a Map: Best Practices for U.S Bike Routes
Project for Public Spaces & National Center for Biking and Walking
Ride the Storm: Navigating Through Unstable Periods / Katerina Rudko (Belka G...
Ride the Storm: Navigating Through Unstable Periods / Katerina Rudko (Belka G...
DevGAMM Conference
Barbie - Brand Strategy Presentation
Barbie - Brand Strategy Presentation
Erica Santiago
Good Stuff Happens in 1:1 Meetings: Why you need them and how to do them well
Good Stuff Happens in 1:1 Meetings: Why you need them and how to do them well
Saba Software
Introduction to C Programming Language
Introduction to C Programming Language
Simplilearn
En vedette
(20)
How to Prepare For a Successful Job Search for 2024
How to Prepare For a Successful Job Search for 2024
Social Media Marketing Trends 2024 // The Global Indie Insights
Social Media Marketing Trends 2024 // The Global Indie Insights
Trends In Paid Search: Navigating The Digital Landscape In 2024
Trends In Paid Search: Navigating The Digital Landscape In 2024
5 Public speaking tips from TED - Visualized summary
5 Public speaking tips from TED - Visualized summary
ChatGPT and the Future of Work - Clark Boyd
ChatGPT and the Future of Work - Clark Boyd
Getting into the tech field. what next
Getting into the tech field. what next
Google's Just Not That Into You: Understanding Core Updates & Search Intent
Google's Just Not That Into You: Understanding Core Updates & Search Intent
How to have difficult conversations
How to have difficult conversations
Introduction to Data Science
Introduction to Data Science
Time Management & Productivity - Best Practices
Time Management & Productivity - Best Practices
The six step guide to practical project management
The six step guide to practical project management
Beginners Guide to TikTok for Search - Rachel Pearson - We are Tilt __ Bright...
Beginners Guide to TikTok for Search - Rachel Pearson - We are Tilt __ Bright...
Unlocking the Power of ChatGPT and AI in Testing - A Real-World Look, present...
Unlocking the Power of ChatGPT and AI in Testing - A Real-World Look, present...
12 Ways to Increase Your Influence at Work
12 Ways to Increase Your Influence at Work
ChatGPT webinar slides
ChatGPT webinar slides
More than Just Lines on a Map: Best Practices for U.S Bike Routes
More than Just Lines on a Map: Best Practices for U.S Bike Routes
Ride the Storm: Navigating Through Unstable Periods / Katerina Rudko (Belka G...
Ride the Storm: Navigating Through Unstable Periods / Katerina Rudko (Belka G...
Barbie - Brand Strategy Presentation
Barbie - Brand Strategy Presentation
Good Stuff Happens in 1:1 Meetings: Why you need them and how to do them well
Good Stuff Happens in 1:1 Meetings: Why you need them and how to do them well
Introduction to C Programming Language
Introduction to C Programming Language
2. POLA KUMAN Agustus 2020 (1).docx
1.
1 BULAN AGUSTUS 2020 1.
IGD LB Tabel 1. Distribusi bakteri berdasarkan jenis spesimen No Bakteri/spesimen pus Jumlah 1 Klebsiella pneumoniae ss. pneumoniae 1 1 2 Pseudomonas aeruginosa 2 2 3 Proteus mirabilis 1 1 1 2 1 Klebsiella pneumoniae ss. Pneumoniae Pseudomonas aeruginosa Proteus mirabilis
2.
2 No Bakteri /Spesimen
Antibiotik Resisten (%R) 1 Klebsiella pneumoniae ss. pneumoniae Ampicillin Ampicillin/Sulbactam Piperacillin/Tazobactam Cefazolin Ceftazidime Ceftriaxone Cefepime 1(100) 1(100) 1(100) 1(100) 1(100) 1(100) 1(100) Aztreonam Meropenem Gentamicin Ciprofloxacin Tigecycline Trimethoprim/Sulfamethoxazole 1(100) 1(100) 1(100) 1(100) 1(100) 1(100) 2 Pseudomonas aeruginosa Tigecycline Nitrofurantoin 1(100) 1(100) 3 Proteus mirabilis Tigecycline Nitrofurantoin 1(100) 1(100) No Bakteri /Spesimen Antibiotik Intermediate (%I) 1 Klebsiella pneumoniae ss. pneumoniae Nitrofurantoin 1(100) No Bakteri /Spesimen Antibiotik Sensitif (%S) 1 Klebsiella pneumoniae ss. pneumoniae Amikacin ESBL 1(100) 1(100)
3.
3 2 Pseudomonas aeruginosa Ampicillin Ampici Ampicillin A Ampicillin mpicillin Ampicillin/Sulbactam Piperacillin/Tazobactam Ceftazidime
Ceftriaxone Cefe Cefepime pime Aztreonam 1(100) 1(100) 1(100) 1(100) 1(100) 1(100) 1(100) Meropenem Amikacin Gentamicin Ciprofloxacin ESBL 1(100) 1(100) 1(100) 1(100) 1(100) Proteus mirabilis Ampicillin Ampicillin/Sulbactam Piperacillin/Tazobactam Ceftazidime Ceftriaxone Cefepime Aztreonam 1(100) 1(100) 1(100) 1(100) 1(100) 1(100) 1(100) Meropenem Amikacin Gentamicin Ciprofloxacin ESBL 1(100) 1(100) 1(100) 1(100) 1(100) 2. IGD ANAK Tabel 2. Distribusi bakteri berdasarkan jenis spesimen No Bakteri/spesimen tinja Jumlah 1 Klebsiella pneumoniae ss. pneumoniae 1 1
4.
4 No Bakteri /Spesimen
Antibiotik Resisten (%R) 1 Klebsiella pneumoniae ss. pneumoniae Ampicillin Cefazolin Ceftazidime Ceftriaxone Aztreonam ESBL 1(100) 1(100) 1(100) 1(100) 1(100) 1(100) No Bakteri /Spesimen Antibiotik Intermediate (%I) 1 Klebsiella pneumoniae ss. pneumoniae Ampicillin/Sulbactam 1(100) 1 Klebsiella pneumoniae ss. pneumoniae
5.
5 No Bakteri /Spesimen
Antibiotik Sensitif (%S) 1 Klebsiella pneumoniae ss. pneumoniae Piperacillin/ Tazobactam Cefepime Meropenem Amikacin Gentamicin Ciprofloxacin Tigecycline 1(100) 1(100) 1(100) 1(100) 1(100) 1(100) 1(100) Nitrofurantoin 1(100) 3. IGD BEDAH Tabel 3. Distribusi bakteri berdasarkan jenis spesimen No Bakteri/spesimen pus Jumlah 1 Escherichia coli 1 1 1 Escherichia coli
6.
6 No Bakteri /Spesimen
Antibiotik Resisten (%R) 1 Escherichia coli Ampicillin Cefazolin Ceftazidime Ceftriaxone Aztreonam ESBL 1(100) 1(100) 1(100) 1(100) 1(100) 1(100) No Bakteri /Spesimen Antibiotik Intermediate (% ) 1 Escherichia coli Ampicillin/Sulbactam Cefepime Nitrofurantoin 1(100) 1(100) 1(100) No Bakteri /Spesimen Antibiotik Sensitif (%S) 1 Escherichia coli Piperacillin/ Tazobactam Cefepime Meropenem Amikacin Tigecycline 1(100) 1(100) 1(100) 1(100) 1(100)
7.
7 4. IGD NON
BEDAH Tabel 4. Distribusi bakteri berdasarkan jenis spesimen No Bakteri/spesimen pus Jumlah 1 Kluyvera sp. 1 1 No Bakteri /Spesimen Antibiotik Sensitif (%S) 1 Kluyvera sp. Ampicillin Ampicillin/Sulbactam Piperacillin/Tazobactam Ceftazidime Ceftriaxone Cefepime Aztreonam 1(100) 1(100) 1(100) 1(100) 1(100) 1(100) 1(100) 1 Kluyvera sp.
8.
8 Meropenem Amikacin Gentamicin
Ciprofloxacin Tigecycline Nitrofurantoin ESBL 1(100) 1(100) 1(100) 1(100) 1(100) 1(100) 1(100) 5. LONTARA 1 ATAS DEPAN Tabel 5. Distribusi bakteri berdasarkan jenis spesimen No Bakteri/spesimen urine Sputum Pus Jumlah 1 Acinetobacter baumannii 1 1 2 Escherichia coli 1 1 3 Klebsiella pneumoniae ss. pneumoniae 1 1 1 1 1 Acinetobacter baumannii Escherichia coli Klebsiella pneumoniae ss. pneumoniae
9.
9 No Bakteri /Spesimen
Antibiotik Resisten (%R) 1 Acinetobacter baumannii Ampicillin/Sulbactam Piperacillin/Tazobactam Cefazolin Ceftazidime Ceftriaxone Cefepime Meropenem 1(100) 1(100) 1(100) 1(100) 1(100) 1(100) 1(100) Amikacin Gentamicin Ciprofloxacin Tigecycline 1(100) 1(100) 1(100) 1(100) 2 Escherichia coli Ampicillin Ampicillin/Sulbactam 1(100) 1(100) No Bakteri /Spesimen Antibiotik Intermediate (% ) 1 Klebsiella pneumoniae ss. pneumoniae Ampicillin Nitrofurantoin 1(100) 1(100) No Bakteri /Spesimen Antibiotik Sensitif (%S) 1 Acinetobacter baumannii ESBL 1(100) 2 Escherichia coli Piperacillin/Tazobactam Ceftazidime Ceftriaxone Cefepime Aztreonam Meropenem 1(100) 1(100) 1(100) 1(100) 1(100) 1(100)
10.
10 Amikacin Gentamicin Ciprofloxacin
Tigecycline Nitrofurantoin ESBL 1(100) 1(100) 1(100) 1(100) 1(100) 1(100) 3 Klebsiella pneumoniae ss. pneumoniae Ampicillin/Sulbactam Piperacillin/Tazobactam Ceftazidime Ceftriaxone Cefepime Aztreonam 1(100) 1(100) 1(100) 1(100) 1(100) 1(100) Meropenem Amikacin Gentamicin Ciprofloxacin Tigecycline ESBL 1(100) 1(100) 1(100) 1(100) 1(100) 1(100) 6. LONTARA 1 ATAS BELAKANG Tabel 6. Distribusi bakteri berdasarkan jenis spesimen No Bakteri/spesimen sputum tinja Darah Pus Cairan pleura Jumlah 1 Enterobacter aerogenes 1 1 2 Escherichia coli 1 1 2 3 Klebsiella pneumoniae ss. pneumoniae 2 2 4 Stenotrophomonas maltophilia 1 1 5 Staphylococcus haemolyticus 2 2
11.
11 No Bakteri /Spesimen
Antibiotik Resisten (%R) 1 Enterobacter aerogenes Cefazolin Tigecycline 1(100) 1(100) 2. Escherichia coli Ampicillin Ampicillin/Sulbactam Cefazolin Ceftazidime Ceftriaxone Cefepime 2(100) 2(50) 2(50) 2(50) 2(50) 2(50) Aztreonam Ciprofloxacin Trimethoprim/Sulfamethoxazole ESBL 2(50) 2(50) 2(100) 2(50) 3 Klebsiella pneumoniae ss. pneumoniae Ampicillin Trimethoprim/Sulfame thoxazole 2(50) 2(50) 4 Staphylococcus Ciprofloxacin Levofloxacin Tigecycline Trimethoprim/Sulfamethoxazole Erythromycin Nitrofurantoin 1 2 2 1 2 Enterobacter aerogenes Escherichia coli Klebsiella pneumoniae ss. pneumoniae Stenotrophomonas maltophilia Staphylococcus haemolyticus
12.
12 haemolyticus 2(100) 2(100)
2(50) 2(50) 2(100) 2(100) Quinupristin/Dalfopristin Tetracycline Vancomycin 2(100) 2(50) 2(100) No Bakteri /Spesimen Antibiotik Intermediate (% ) 1 Enterobacter aerogenes Ampicillin Nitrofurantoin 1(100) 1(100) 2 Escherichia coli Ampicillin/Sulbactam Piperacillin/Tazobactam Ciprofloxacin 2(50) 2(50) 2(50) 3 Klebsiella pneumoniae ss. pneumoniae Ampicillin Nitrofurantoin 2(50) 2(50) 4 Staphylococcus haemolyticus Gentamicin 2(50) No Bakteri /Spesimen Antibiotik Sensitif (%S) 1 Enterobacter aerogenes Ampicillin/Sulbactam Piperacillin/Tazobactam Ceftazidime Ceftriaxone Cefepime Aztreonam Meropenem 1(100) 1(100) 1(100) 1(100) 1(100) 1(100) 1(100) Amikacin Gentamicin Ciprofloxacin ESBL
13.
13 1(100) 1(100) 1(100)
1(100) 2 Escherichia coli Piperacillin/Tazobactam Ceftazidime Ceftriaxone Cefepime Aztreonam Meropenem 2(50) 2(50) 2(50) 2(50) 2(50) 2(100) Amikacin Gentamicin Tigecycline Nitrofurantoin ESBL 2(100) 2(100) 2(100) 2(100) 2(50) 3 Klebsiella pneumoniae ss. pneumoniae Ampicillin/Sulbactam Piperacillin/Tazobactam Ceftazidime Ceftriaxone Cefepime Aztreonam 2(100) 2(100) 2(100) 2(100) 2(100) 2(100) Meropenem Amikacin Gentamicin Ciprofloxacin Tigecycline Nitrofurantoin 2(100) 2(100) 2(100) 2(100) 2(100) 2(50) ESBL 2(100) 4 Stenotrophomonas maltophilia ESBL 1(100) 5 Staphylococcus haemolyticus Gentamicin Tigecycline Clindamycin Linezolid Nitrofurantoin Quinupristin/Dalfopristin 2(50) 2(50) 2(100) 2(100) 2(100) 2(100) Tetracycline Vancomycin ESBL 2(50) 2(100) 2(100)
14.
14 7. LONTARA 1
BAWAH DEPAN Tabel 7. Distribusi bakteri berdasarkan jenis spesimen No Bakteri/spesimen pus darah Sputum urine Jumlah 1 Citrobacter freundii 1 1 2 Escherichia coli 1 1 3 Staphylococcus haemolyticus 1 1 2 4 Staphylococcus simulans 1 1 1 1 2 1 Citrobacter freundii Escherichia coli Staphylococcus haemolyticus Staphylococcus simulans
15.
15 No Bakteri /Spesimen
Antibiotik Resisten (%R) 1 Citrobacter freundii Ampicillin Ampicillin/Sulbactam Piperacillin/Tazobactam Cefazolin Ceftazidime Ceftriaxone Aztreonam 1(100) 1(100) 1(100) 1(100) 1(100) 1(100) 1(100) Gentamicin Trimethoprim/Sulfame thoxazole 1(100) 1(100) 2 Escherichia coli Ampicillin Ampicillin/Sulbactam Cefazolin Ceftazidime Ceftriaxone Aztreonam 1(100) 1(100) 1(100) 1(100) 1(100) 1(100) Ciprofloxacin ESBL 1(100) 1(100) 3 Staphylococcus haemolyticus Gentamicin Ciprofloxacin Levofloxacin Tigecycline Trimethoprim/Sulfamethoxazole Clindamycin 2(100) 2(100) 2(100) 2(50) 2(50) Erythromycin Moxifloxacin Oxacillin Rifampin 2(100) 2(100) 2(100) 2(50) 4 Staphylococcus simulans Ciprofloxacin Levofloxacin Erythromycin Oxacillin 1(100) 1(100) 1(100) 1(100)
16.
16 No Bakteri /Spesimen
Antibiotik Intermediate (% ) 1 Citrobacter freundii Ciprofloxacin 1(100) 2 Staphylococcus simulans Gentamicin Moxifloxacin 1(100) 1(100) No Bakteri /Spesimen Antibiotik Sensitif (%S) 1 Citrobacter freundii Cefepime Meropenem Amikacin Tigecycline Nitrofurantoin ESBL 1(100) 1(100) 1(100) 1(100) 1(100) 1(100) 2 Escherichia coli Piperacillin/Tazobactam Cefepime Meropenem Amikacin Gentamicin Tigecycline 1(100) 1(100) 1(100) 1(100) 1(100) 1(100) Nitrofurantoin 1(100) 3 Staphylococcus haemolyticus Tigecycline Linezolid Nitrofurantoin Quinupristin/Dalfopristin Rifampin Tetracycline 2(50) 1(100) 1(100) 1(100) 2(50) 1(100) Vancomycin ESBL 1(100) 1(100) 4 Staphylococcus simulans Tigecycline Clindamycin Linezolid Nitrofurantoin Quinupristin/Dalfopristin Rifampin 1(100) 1(100) 1(100) 1(100) 1(100) 1(100)
17.
17 Tetracycline Vancomycin ESBL 1(100)
1(100) 1(100) 8. LONTARA 1 BAWAH BELAKANG Tabel 8. Distribusi bakteri berdasarkan jenis spesimen No Bakteri/spesimen sputum darah pus Jumlah 1 Enterococcus faecalis 1 1 2 Staphylococcus aureus ss. aureus 2 2 4 3 Staphylococcus haemolyticus 1 1 1 4 1 Enterococcus faecalis Staphylococcus aureus ss. aureus Staphylococcus haemolyticus
18.
18 No Bakteri /Spesimen
Antibiotik Resisten (%R) 1 Enterococcus faecalis Ciprofloxacin Levofloxacin Quinupristin/Dalfopristin Tetracycline 1(100) 1(100) 1(100) 1(100) 2 Staphylococc Staphylococcus haemolyticus us haemolyticus Staphylococcus haemolyticus Gentamicin Ciprofloxacin Levofloxacin Erythromycin 1(100) 1(100) 1(100) 1(100) Moxifloxacin Oxacillin Rifampin 1(100) 1(100) No Bakteri /Spesimen Antibiotik Intermediate (% ) 1 Enterococcus faecalis Erythromycin Linezolid 1(100) 1(100) No Bakteri /Spesimen Antibiotik Sensitif (%S) 1 Enterococcus faecalis Ampicillin Tigecycline Erythromycin Nitrofurantoin Vancomycin Gentamicin-High Streptomycin- High 1(100) 1(100) 1(100) 1(100) 1(100) 1(100) 1(100) ESBL 1(100) 2 Staphylococcus aureus ss. Gentamicin Ciprofloxacin Levofloxacin Tigecycline Clindamycin Erythromycin
19.
19 aureus 1(100) 1(100)
1(100) 1(100) 1(100) 1(100) Linezolid Moxifloxacin Nitrofurantoin Oxacillin Quinupristin/Dalfopristin Rifampin 1(100) 1(100) 1(100) 1(100) 1(100) 1(100) Tetracycline Vancomycin ESBL 1(100) 1(100) 1(100) 3 Staphylococcus haemolyticus Tigecycline Clindamycin Linezolid Nitrofurantoin Quinupristin/Dalfopristin Tetracycline 1(100) 1(100) 1(100) 1(100) 1(100) 1(100) Vancomycin ESBL 1(100) 1(100) 9. LONTARA 2 ATAS DEPAN Tabel 9. Distribusi bakteri berdasarkan jenis spesimen No Bakteri/spesimen urine pus Jumlah 1 Enterobacter cloacae 1 1 2 Escherichia coli 1 1
20.
20 No Bakteri /Spesimen
Antibiotik Resisten (%R) 1 Enterobacter cloacae Cefazolin Tigecycline 1(100) 1(100) 2 Escherichia coli Ampicillin Trimethoprim/Sulfamethoxazole 1(100) 1(100) No Bakteri /Spesimen Antibiotik Intermediate (% ) 1 Enterobacter cloacae Ampicillin 1(100) 2 Escherichia coli Gentamicin Moxifloxacin 1(100) 1(100) 1 1 Enterobacter cloacae Escherichia coli
21.
21 No Bakteri /Spesimen
Antibiotik Sensitif (%S) 1 Enterobacter cloacae Ampicillin/Sulbactam Piperacillin/Tazobactam Ceftazidime Ceftriaxone Cefepime Aztreonam Meropenem 1(100) 1(100) 1(100) 1(100) 1(100) 1(100) 1(100) Amikacin Gentamicin Ciprofloxacin Nitrofurantoin Nitrofurantoi 1(100) 1(100) 1(100) 1(100) 1(100) 2 Escherichia coli Ampicillin/Sulbactam Piperacillin/Tazobactam Ceftazidime Ceftriaxone Cefepime Aztreonam Meropenem 1(100) 1(100) 1(100) 1(100) 1(100) 1(100) 1(100) Amikacin Gentamicin Ciprofloxacin Nitrofurantoin 1(100) 1(100) 1(100) 1(100) 10. LONTARA 2 ATAS BELAKANG Tabel 10. Distribusi bakteri berdasarkan jenis spesimen No Bakteri/spesimen sputum Jumlah 1 Empedobacter sp. 1 1 2 Pseudomonas aeruginosa 1 1
22.
22 No Bakteri /Spesimen
Antibiotik Resisten (%R) 1 Empedobacter sp. Ampicillin Cefazolin 1(100) 1(100) 2. Pseudomonas aeruginosa Cefazolin Tigecycline 1(100) 1(100) No Bakteri /Spesimen Antibiotik Intermediate (% ) 1 Empedobacter sp. Nitrofurantoin 1(100) 1 1 Empedobacter sp. Pseudomonas aeruginosa
23.
23 No Bakteri /Spesimen
Antibiotik Sensitif (%S) 1 Empedobacter sp. Ampicillin/Sulbactam Piperacillin/Tazobactam Ceftazidime Ceftriaxone Cefepime Aztreonam Meropenem 1(100) 1(100) 1(100) 1(100) 1(100) 1(100) 1(100) Amikacin Gentamicin Ciprofloxacin Tigecycline ESBL 1(100) 1(100) 1(100) 1(100) 1(100) 2 Pseudomonas aeruginosa Piperacillin/Tazobactam Ceftazidime Cefepime Aztreonam Meropenem Amikacin Gentamicin 1(100) 1(100) 1(100) 1(100) 1(100) 1(100) 1(100) Ciprofloxacin ESBL 1(100) 1(100) 11. LONTARA 2 BAWAH DEPAN Tabel 11. Distribusi bakteri berdasarkan jenis spesimen No Bakteri/spesimen darah sputum pus Jumlah 1 Acinetobacter baumannii 1 1 2 2 Escherichia coli 1 1 3 Vibrio mimicus 1 1
24.
24 No Bakteri /Spesimen Antibiotik Resisten (%R) 1 Acinetobacter baumannii Ampicillin/Sulbactam
Piperacillin/Tazobactam Cefazolin Ceftazidime Ceftriaxone Cefepime 2(50) 2(50) 2(100) 2(50) 2(100) 2(50) Aztreonam Meropenem Gentamicin Ciprofloxacin Tigecycline 1(100) 2(50) 2(50) 2(50) 2(50) 2. Escherichia coli Ampicillin Ampicillin/Sulbactam Piperacillin/Tazobactam Cefazolin Ceftazidime Ceftriaxone 2 1 1 Acinetobacter baumannii Escherichia coli Vibrio mimicus
25.
25 1(100) 1(100) 1(100)
1(100) 1(100) 1(100) Cefepime Aztreonam Ertapenem Cefepime Aztreonam Ertapenem 1(100) 1(100) 1(100) 1(100) 1(100) 1(100) 3 Vibrio mimicus Ampicillin Ampicillin/Sulbactam Cefazolin Ceftazidime Amikacin Gentamicin 1(100) 1(100) 1(100) 1(100) 1(100) 1(100) Ciprofloxacin Tigecycline Trimethoprim/Sulfamethoxazole 1(100) 1(100) 1(100) No Bakteri /Spesimen Antibiotik Intermediate (% ) 1 Acinetobacter baumannii Amikacin 2(50) 2 Escherichia coli Nitrofurantoin 1(100) 3 Vibrio mimicus Piperacillin/Tazobactam 1(100) No Bakteri /Spesimen Antibiotik Sensitif (%S) 1 Acinetobacter baumannii Ampicillin/Sulbactam Piperacillin/Tazobactam Ceftazidime Cefepime Meropenem Amikacin Gentamicin 2(50) 2(50) 2(50) 2(50) 2(50) 2(50) 2(50)
26.
26 Ciprofloxacin Tigecycline ESBL 2(50)
2(50) 2(100) 2 Escherichia coli Amikacin Gentamicin Tigecycline ESBL 1(100) 1(100) 1(100) 1(100) 3 Vibrio mimicus Cefepime Meropenem ESBL 1(100) 1(100) 1(100) 12. LONTARA 2 BAWAH BELAKANG Tabel 12. Distribusi bakteri berdasarkan jenis spesimen No Bakteri/spesimen sputum jaringan pus Jumlah 1 Klebsiella pneumoniae ss. ozaenae 1 1 2 Pseudomonas aeruginosa 2 2 3 Proteus mirabilis 1 1
27.
27 No Bakteri /Spesimen
Antibiotik Resisten (%R) 1 Ampicillin Ciprofloxacin Trimethoprim/Sulfamethoxazole 1 2 1 Klebsiella pneumoniae ss. ozaenae Pseudomonas aeruginosa Proteus mirabilis
28.
28 Klebsiella pneumoniae ss. ozaenae 1(100) 1(100)
1(100) 2 Pseudomonas aeruginosa Cefazolin Tigecycline 2(100) 2(100) 3 Proteus mirabilis Ampicillin Ampicillin/Sulbactam Cefazolin Ceftazidime Ceftriaxone Gentamicin 1(100) 1(100) 1(100) 1(100) 1(100) 1(100) Tigecycline Trimethoprim/Sulfamethoxazole Nitrofurantoin 1(100) 1(100) 1(100) No Bakteri /Spesimen Antibiotik Intermediate (% ) 1 Klebsiella pneumoniae ss. ozaenae Ampicillin/Sulbactam 1(100) 2 Pseudomonas aeruginosa Ciprofloxacin 2(50) No Bakteri /Spesimen Antibiotik Sensitif (%S) 1 Klebsiella pneumoniae ss. ozaenae Piperacillin/Tazobactam Ceftazidime Ceftriaxone Cefepime Aztreonam Meropenem Amikacin 1(100) 1(100) 1(100) 1(100) 1(100) 1(100) 1(100)
29.
29 Gentamicin Tigecycline Nitrofurantoin
ESBL 1(100) 1(100) 1(100) 1(100) 2 Pseudomonas aeruginosa Piperacillin/Tazobactam Ceftazidime Cefepime Aztreonam Meropenem Amikacin Gentamicin 2(100) 2(100) 2(100) 1(100) 2(100) 2(100) 2(100) Ciprofloxacin ESBL 2(100) 2(50) 2(100) 3 Proteus mirabilis Piperacillin/Tazobactam Ceftriaxone Cefepime Aztreonam Amikacin Ciprofloxacin 1(100) 1(100) 1(100) 1(100) 1(100) 1(100) 1(100) ESBL 1(100) 13. LONTARA 3 ATAS DEPAN Tabel 13. Distribusi bakteri berdasarkan jenis spesimen No Bakteri/spesimen darah Jumlah 1 Staphylococcus hominis ss. hominis 1 1
30.
30 No Bakteri /Spesimen
Antibiotik Sensitif (%S) 1 Staphylococcus hominis ss. hominis Gentamicin Ciprofloxacin levofloxasin Tigecycline Clindamycin Erytromicyn Linezolid 1(100) 1(100) 1(100) 1(100) 1(100) 1(100) 1(100) Moxifloxacin Nitrofurantoin oxacillin Quinupristin/Dalfopristin Rifampicin Tetracycline Vancomycin 1(100) 1(100) 1(100) 1(100) 1(100) 1(100) 1(100) ESBL 1(100) 14. LONTARA 3 ATAS BELAKANG Tabel 14. Distribusi bakteri berdasarkan jenis spesimen No Bakteri/spesimen sputum jumlah 1 Staphylococcus hominis ss. hominis
31.
31 1 Enterobacter aerogenes
1 1 No Bakteri /Spesimen Antibiotik Resisten (%R) 1 Enterobacter aerogenes Ampicillin Cefazolin 1(100) 1(100) No Bakteri /Spesimen Antibiotik Sensitif (%S) 1 Enterobacter aerogenes Ampicillin/Sulbactam Piperacillin/Tazobactam Ceftazidime Ceftriaxone Cefepime Aztreonam Meropenem 1(100) 1(100) 1(100) 1(100) 1(100) 1(100) 1(100) Amikacin Gentamicin Ciprofloxacin Tigecycline Nitrofurantoin ESBL 1(100) 1(100) 1(100) 1(100) 1(100) 1(100) 1 Enterobacter aerogenes
32.
32 15. LONTARA 3
BAWAH DEPAN Tabel 15. Distribusi bakteri berdasarkan jenis spesimen No Bakteri/specimen Cairan otak pus tinja urine Jumlah 1 Acinetobacter baumannii 1 1 2 2 Escherichia coli 1 1 3 Enterococcus faecium 1 1 4 Klebsiella pneumoniae ss. pneumoniae 1 3 4 5 Staphylococcus epidermidis 1 1 2 1 1 4 1 Acinetobacter baumannii Escherichia coli Enterococcus faecium Klebsiella pneumoniae ss. pneumoniae Staphylococcus epidermidis
33.
33 No Bakteri /Spesimen Antibiotik Resisten (%R) 1 Acinetobacter baumannii Ampicillin/Sulbactam
Piperacillin/Tazobactam Cefazolin Ceftazidime Ceftriaxone Cefepime 2(50) 2(100) 2(100) 2(100) 2(100) 2(100) Meropenem Gentamicin Ciprofloxacin Tigecycline 2(100) 2(50) 2(100) 2(100) 2 Escherichia coli Ampicillin Ampicillin/Sulbactam Piperacillin/Tazob actam Cefazolin Ceftazidime Ceftriaxone 1(100) 1(100) 1(100) 1(100) 1(100) 1(100) Cefepime Aztreonam Ertapenem Meropenem Ciprofloxacin Trimethoprim/Sulfamet hoxazole 1(100) 1(100) 1(100) 1(100) 1(100) 1(100) 3 Enterococcus faecium Ampicillin Ciprofloxacin Levofloxacin Erythromycin Nitrofurantoin 1(100) 1(100) 1(100) 1(100) 1(100) 4 Klebsiella pneumoniae ss. pneumonia Ampicillin Ampicillin/Sulbactam Piperacillin/Tazobactam Cefazolin Ceftazidime Ceftriaxone 4(100) 4(75) 4(50) 4(75) 4(50) 4(75) Cefepime Aztreonam Ertapenem Meropenem Gentamicin Ciprofloxacin 4(50) 4(75) 4(25) 4(25) 4(50) 4(50) Tigecycline Trimethoprim/Sulfamethoxa zole Nitrofurantoin ESBL 4(75) 4(75) 4(25) 3(66.7)
34.
34 5 Staphylococcus epidermidis Oxacillin 1(100) No Bakteri /Spesimen
Antibiotik Intermediate (% ) 1 Acinetobacter baumannii Ampicillin/Sulbactam Amikacin Gentamicin 2(50) 2(50) 2(50) 2 Klebsiella pneumoniae ss. pneumonia Ceftazidime Gentamicin Ciprofloxacin Nitrofurantoin 4(25) 4(25) 4(25) 4(25) No Bakteri /Spesimen Antibiotik Sensitif (%S) 1 Acinetobacter baumannii Amikacin ESBL 2(50) 2(100) 2 Escherichia coli Amikacin Gentamicin Tigecycline Nitrofurantoin ESBL 1(100) 1(100) 1(100) 1(100) 1(100) 3 Enterococcus faecium Tigecycline Linezolid Quinupristin/Dalfopristin Tetracycline Vancomycin Gentamicin-High 1(100) 1(100) 1(100) 1(100) 1(100) 1(100) Streptomycin-High ESBL
35.
35 1(100) 1(100) 4 Klebsiella pneumoniae
ss. pneumonia Ampicillin/Sulbactam Piperacillin/Tazobactam Ceftazidime Ceftriaxone Cefepime Aztreonam 4(25) 4(50) 4(25) 4(25) 4(50) 4(25) Meropenem Amikacin Gentamicin Ciprofloxacin Tigecycline Nitrofurantoin 4(75) 4(100) 4(25) 4(25) 4(25) 4(25) ESBL 3 (33.3) 5 Staphylococcus epidermidis Gentamicin Ciprofloxacin Levofloxacin Tigecycline Clindamycin Erythromycin 1(100) 1(100) 1(100) 1(100) 1(100) 1(100) Linezolid Moxifloxacin Nitrofurantoin Quinupristin/Dalfopristin Rifampin Tetracycline 1(100) 1(100) 1(100) 1(100) 1(100) 1(100) Vancomycin ESBL 1(100) 1(100) 16. LONTARA 3 BAWAH BELAKANG Tabel 16. Distribusi bakteri berdasarkan jenis spesimen No Bakteri/spesimen sputum Jumlah 1 Klebsiella pneumoniae ss. pneumoniae 1 1
36.
36 2 Staphylococcus aureus
ss. aureus 1 1 3 Staphylococcus epidermidis 1 1 No Bakteri /Spesimen Antibiotik Resisten (%R) 1 Klebsiella pneumoniae ss. pneumoniae Ampicillin Ampicillin/Sulbactam Tigecycline Nitrofurantoin 1(100) 1(100) 1(100) 1(100) 2 Staphylococcus epidermidis Gentamicin Ciprofloxacin Levofloxacin Trimethoprim/Sulfamethoxazole Clindamycin Erythromycin 1(100) 1(100) 1(100) 1(100) Moxifloxacin Oxacillin 1 1 1 Klebsiella pneumoniae ss. pneumoniae Staphylococcus aureus ss. aureus Staphylococcus epidermidis
37.
37 1(100) 1(100) No Bakteri
/Spesimen Antibiotik Intermediate (% ) 1 Klebsiella pneumoniae ss. pneumoniae Piperacillin/Tazobactam 1(100) No Bakteri /Spesimen Antibiotik Sensitif (%S) 1 Klebsiella pneumoniae ss. pneumoniae Ceftazidime Ceftriaxone Cefepime Aztreonam Meropenem Amikacin Gentamicin 1(100) 1(100) 1(100) 1(100) 1(100) 1(100) 1(100) Ciprofloxacin Nitrofurantoin 1(100) 1(100) 2 Staphylococcus aureus ss. aureus Gentamicin Ciprofloxacin Levofloxacin Tigecycline Clindamycin Erythromycin 1(100) 1(100) 1(100) 1(100) 1(100) 1(100) Linezolid Moxifloxacin Nitrofurantoin Oxacillin Quinupristin/Dalfopristin Rifampin 1(100) 1(100) 1(100) 1(100) 1(100) 1(100) Tetracycline Vancomycin ESBL 1(100) 1(100) 1(100) 3 Staphylococcus epidermidis Tigecycline Linezolid Nitrofurantoin Quinupristin/Dalfopristin Rifampin Tetracycline
38.
38 1(100) 1(100) 1(100)
1(100) 1(100) 1(100) Vancomycin ESBL 1(100) 1(100) 17. LONTARA 4 ATAS DEPAN Tabel 17. Distribusi bakteri berdasarkan jenis spesimen No Bakteri/spesimen tinja urine pus darah Jumlah 1 Escherichia coli 1 1 2 2 Pseudomonas aeruginosa 1 1 3 Staphylococcus haemolyticus 1 1 2 1 1 Escherichia coli Pseudomonas aeruginosa Staphylococcus haemolyticus
39.
39 No Bakteri /Spesimen
Antibiotik Resisten (%R) 1 Escherichia coli Ampicillin Ampicillin/Sulbactam Cefazolin Ceftazidime Ceftriaxone Aztreonam 2(100) 1(50) 2(100) 2(50) 2(100) 2(100) Gentamicin Ciprofloxacin Trimethoprim/Sulfamethoxazole 2(50) 2(50) 2(100) 2 Pseudomonas aeruginosa Cefazolin Tigecycline 1(100) 1(100) 3 Staphylococcus haemolyticus Gentamicin Ciprofloxacin Levofloxacin Trimethoprim/Sulfamethoxazole Erythromycin Moxifloxacin 1(100) 1(100) 1(100) 1(100) 1(100) 1(100) Oxacillin Rifampin 1(100) 1(100) No Bakteri /Spesimen Antibiotik Intermediate (% ) 1 Ampicillin/Sulbactam
40.
40 Escherichia coli 2(50) No
Bakteri /Spesimen Antibiotik Sensitif (%S) 1 Escherichia coli Piperacillin/Tazobactam Ceftazidime Cefepime Meropenem Amikacin Gentamicin Ciprofloxacin 2(100) 2(50) 2(100) 2(100) 2(100) 2(50) 2(50) Tigecycline Nitrofurantoin 2(100) 2(100) 2 Escherichia coli Piperacillin/Tazobactam Ceftazidime Cefepime Aztreonam Meropenem Amikacin 1(100) 1(100) 1(100) 1(100) 1(100) 1(100) Gentamicin Ciprofloxacin ESBL 1(100) 1(100) 1(100) 3 Staphylococcus haemolyticus Tigecycline Clindamycin Linezolid Nitrofurantoin Quinupristin/Dalfopristin Tetracycline 1(100) 1(100) 1(100) 1(100) 1(100) 1(100) Vancomycin ESBL 1(100) 1(100)
41.
41 18. LONTARA 4
ATAS BELAKANG Tabel 18. Distribusi bakteri berdasarkan jenis spesimen No Bakteri/spesimen fn tinja Jumlah 1 Citrobacter freundii 1 1 2 Escherichia coli 1 1 3 Klebsiella pneumoniae ss. pneumoniae 1 1 1 1 1 Citrobacter freundii Escherichia coli Klebsiella pneumoniae ss. pneumoniae
42.
42 No Bakteri /Spesimen
Antibiotik Resisten (%R) 1 Citrobacter freundii Ampicillin Ampicillin/Sulbactam Piperacillin/Tazobactam Cefazolin Ceftazidime Ceftriaxone 1(100) 1(100) 1(100) 1(100) 1(100) 1(100) Aztreonam Trimethoprim/Sulfamethoxazole 1(100) 1(100) 3 Klebsiella pneumoniae ss. pneumoniae Ampicillin Ampicillin/Sulbactam Cefazolin Ceftazidime Ceftriaxone Aztreonam 1(100) 1(100) 1(100) 1(100) 1(100) 1(100) Tigecycline ESBL 1(100) 1(100) No Bakteri /Spesimen Antibiotik Sensitif (%S) 1 Citrobacter freundii Cefepime Meropenem Amikacin Gentamicin Ciprofloxacin Tigecycline Nitrofurantoin 1(100) 1(100) 1(100) 1(100) 1(100) 1(100) 1(100) ESBL 1(100) 2 Escherichia coli Ampicillin Ampicillin/Sulbactam Piperacillin/Tazobactam Ceftazidime Ceftriaxone Cefepime 1(100) 1(100) 1(100) 1(100) 1(100) 1(100) Aztreonam Meropenem Amikacin Gentamicin Ciprofloxacin Tigecycline
43.
43 1(100) 1(100) 1(100)
1(100) 1(100) 1(100) Nitrofurantoin ESBL 1(100) 1(100) 3 Klebsiella pneumoniae ss. pneumoniae Piperacillin/Tazobactam Cefepime Meropenem Amikacin Gentamicin Ciprofloxacin 1(100) 1(100) 1(100) 1(100) 1(100) 1(100) Nitrofurantoin 1(100) 19. ICU Tabel 20. Distribusi bakteri berdasarkan jenis spesimen No Bakteri/spesimen darah sputum Jumlah 1 Acinetobacter baumannii 2 2 2 Achromobacter xylosoxidans ss. denitrifican 1 1 3 Klebsiella pneumoniae ss. pneumoniae 1 1 4 Burkholderia cepacia 2 2 5 Stenotrophomonas maltophilia 1 1
44.
44 No Bakteri /Spesimen Antibiotik Resisten (%R) 1 Acinetobacter baumannii Ampicillin/Sulbactam
Piperacillin/Tazobactam Cefazolin Ceftazidime Ceftriaxone Cefepime 2(100) 2(100) 2(100) 2(100) 2(100) 2(100) Meropenem Amikacin Gentamicin Ciprofloxacin Tigecycline Trimethoprim/Sulfamethoxazole 2(100) 2(50) 2(100) 2(100) 2(100) 2(100) 2 Achromobacter xylosoxidans ss. denitrifican Cefazolin Ceftriaxone Cefepime Aztreonam Amikacin Gentamicin 1(100) 1(100) 1(100) 1(100) 1(100) 1(100) Ciprofloxacin Tigecycline 1(100) 1(100) 3 Klebsiella pneumoniae ss. pneumoniae Ampicillin Ampicillin/Sulbactam Piperacillin/Tazobactam Cefazolin Ceftazidime Ceftriaxone 1(100) 1(100) 1(100) 1(100) 1(100) 1(100) 2 1 1 2 1 Acinetobacter baumannii Achromobacter xylosoxidans ss. denitrifican Klebsiella pneumoniae ss. pneumoniae Burkholderia cepacia Stenotrophomonas maltophilia
45.
45 Aztreonam Meropenem Ciprofloxacin
Tigecycline Trimethoprim/Sulfamethoxazole Nitrofurantoin 1(100) 1(100) 1(100) 1(100) 1(100) 1(100) 4 Burkholderia cepacia Piperacillin/Tazobactam Cefazolin Ceftriaxone Meropenem Amikacin Gentamicin 2(100) 2(100) 2(100) 2(100) 2(100) 2(100) Tigecycline 2(100) 5 Stenotrophomon as maltophilia Trimethoprim/Sulfamethoxazole 1(100) No Bakteri /Spesimen Antibiotik Sensitif (%S) 1 Acinetobacter baumannii Amikacin ESBL 2(50) 2(100) 2 Achromobacter xylosoxidans ss. denitrifican Piperacillin/Tazobactam Ceftazidime ESBL 1(100) 1(100) 1(100) 3 Klebsiella pneumoniae ss. pneumoniae Cefepime Amikacin Gentamicin ESBL 1(100) 1(100) 1(100) 1(100) 4 Burkholderia cepacia Ceftazidime Cefepime Ciprofloxacin ESBL 2(100) 2(100) 2(100) 2(100)
46.
46 5 Stenotrophomonas maltophilia ESBL 1(100) 20. NICU Tabel 21.
Distribusi bakteri berdasarkan jenis spesimen No Bakteri/spesimen darah Jumlah 1 Acinetobacter baumannii 1 1 2 Escherichia coli 1 1 3 Klebsiella pneumoniae ss. pneumoniae 2 2 4 Staphylococcus hominis ss. hominis 2 2 1 1 2 2 Acinetobacter baumannii Escherichia coli Klebsiella pneumoniae ss. pneumoniae Staphylococcus hominis ss. hominis
47.
47 No Bakteri /Spesimen Antibiotik Resisten (%R) 1 Acinetobacter baumannii Cefazolin
Ceftazidime Ceftriaxone Cefepime Gentamicin Ciprofloxacin 1(100) 1(100) 1(100) 1(100) 1(100) 1(100) Tigecycline 1(100) 2 Escherichia coli Ampicillin 1(100) 3 Klebsiella pneumoniae ss. pneumoniae Ampicillin Ampicillin/Sulbactam Cefazolin Ceftazidime Ceftriaxone Aztreonam 2(100) 2(100) 2(100) 2(100) 2(100) 2(100) Gentamicin ESBL 2(100) 2(100) 4 Staphylococcus hominis ss. Hominis Ciprofloxacin Levofloxacin Trimethoprim/Sulfamethoxazole Erytromycin Moxifloxacin Oxacillin 2(50) 2(50) 2(100) 2(100) 2(50) 2(50) Tetracycline 2(50) No Bakteri /Spesimen Antibiotik Intermediate (% ) 1 Ampicillin/Sulbactam
48.
48 Escherichia coli 2(50) No
Bakteri /Spesimen Antibiotik Sensitif (%S) 1 Acinetobacter baumannii Ampicillin/Sulbactam Piperacillin/Tazobactam Meropenem Amikacin ESBL 1(100) 1(100) 1(100) 1(100) 1(100) 2 Escherichia coli Piperacillin/Tazobactam Ceftazidime Ceftriaxone Cefepime Aztreonam Meropenem 1(100) 1(100) 1(100) 1(100) 1(100) 1(100) Amikacin Gentamicin Ciprofloxacin Tigecycline Nitrofurantoin 1(100) 1(100) 1(100) 1(100) 1(100) 3 Klebsiella pneumoniae ss. Pneumonia Piperacillin/Tazobactam Cefepime Meropenem Amikacin Ciprofloxacin Tigecycline 2(100) 2(100) 2(100) 2(100) 2(100) 2(100) Nitrofurantoin 2(100) 4 Staphylococcus hominis ss. Hominis Gentamicin Ciprofloxacin Levofloxacin Tigecycline Clindamycin Erytromycin 2(100) 2(50) 2(50) 2(100) 2(100) 2(50) Linezolid Moxifloxacin Nitrofurantoin Oxacillin Quinupristin/Dalfopristin Rimfapin 2(100) 2(50) 2(100) 2(50) 2(100) 2(100) Tetracycline Vancomycin ESBL
49.
49 2(50) 2(100) 2(100) 21.
PICU Tabel 21. Distribusi bakteri berdasarkan jenis spesimen No Bakteri/spesimen ab tr sputum as cairan otak Jumlah 1 Escherichia coli 1 1 2 Klebsiella pneumoniae ss. pneumoniae 1 1 3 Pseudomonas aeruginosa 1 1 2 4 Stenotrophomonas maltophilia 1 1 5 Sphingomonas paucimobilis 1 1
50.
50 No Bakteri /Spesimen Antibiotik Resisten (%R) 1
Escherichia coli Ampicillin Gentamicin Ciprofloxacin Trimethoprim/Sulfamethoxazole 1(100) 1(100) 1(100) 1(100) 2 Klebsiella pneumoniae ss. pneumoniae Ampicillin Ampicillin/Sulbactam Cefazolin Ceftazidime Ceftriaxone Aztreonam 1(100) 1(100) 1(100) 1(100) 1(100) 1(100) Gentamicin Ciprofloxacin Trimethoprim/Sulfamethoxazole ESBL 1(100) 1(100) 1(100) 1(100) 3 Cefazolin Aztreonam Meropenem Ciprofloxacin Tigecycline 1 1 2 1 1 Escherichia coli Klebsiella pneumoniae ss. pneumoniae Pseudomonas aeruginosa Stenotrophomonas maltophilia Sphingomonas paucimobilis
51.
51 Pseudomonas aeruginosa 2(100) 2(50)
2(50) 2(50) 2(100) 4 Stenotrophomon as maltophilia Trimethoprim/Sulfamethoxazole 1(100) 5 Sphingomonas paucimobilis Ceftazidime Aztreonam 1(100) 1(100) No Bakteri /Spesimen Antibiotik Intermediate (% ) 1 Escherichia coli Ampicillin/Sulbactam 1(100) 2 Klebsiella pneumoniae ss. pneumoniae Nitrofurantoin 1(100)
52.
52 No Bakteri /Spesimen
Antibiotik Sensitif (%S) 1 Escherichia coli Piperacillin/Tazobactam Ceftazidime Ceftriaxone Cefepime Aztreonam Meropenem 1(100) 1(100) 1(100) 1(100) 1(100) 1(100) Amikacin Tigecycline Nitrofurantoin ESBL 1(100) 1(100) 1(100) 1(100) 2 Klebsiella pneumoniae ss. pneumoniae Piperacillin/Tazobactam Cefepime Meropenem Amikacin Tigecycline 1(100) 1(100) 1(100) 1(100) 1(100) 3 Pseudomonas aeruginosa Piperacillin/Tazobactam Ceftazidime Cefepime Aztreonam Meropenem Amikacin 2(100) 2(100) 2(100) 2(50) 2(50) 2(100) Gentamicin Ciprofloxacin ESBL 2(100) 2(50) 2(100) 4 Stenotrophomonas maltophilia ESBL 1(100) 5 Sphingomonas paucimobilis Piperacillin/Tazobactam Ceftriaxone Cefepime Meropenem Amikacin Gentamicin 1(100) 1(100) 1(100) 1(100) 1(100) 1(100) Ciprofloxacin Tigecycline ESBL 1(100) 1(100) 1(100)
53.
53 21. CVCU Tabel 22.
Distribusi bakteri berdasarkan jenis spesimen No Bakteri/spesimen sputum pus Jumlah 1 Acinetobacter junii 1 1 2 Staphylococcus aureus ss. aureus 1 1 3 Staphylococcus hominis ss. hominis 1 1 No Bakteri /Spesimen Antibiotik Resisten (%R) 1 Acinetobacter junii Cefazolin Ceftriaxone Amikacin Tigecycline 1(100) 1(100) 1(100) 1(100) 1 1 1 Acinetobacter junii Staphylococcus aureus ss. aureus Staphylococcus hominis ss. hominis
54.
54 2 Staphylococcus hominis ss. hominis Gentamicin Ciprofloxacin
Trimethoprim/Sulfamethoxazole Clindamycin Erytromycin Moxifloxacin 1(100) 1(100) 1(100) 1(100) 1(100) 1(100) Oxacillin 1(100) No Bakteri /Spesimen Antibiotik Sensitif (%S) 1 Acinetobacter junii Ampicillin/Sulbactam Ceftazidime Cefepime Meropenem Gentamicin Ciprofloxacin 1(100) 1(100) 1(100) 1(100) 1(100) 1(100) ESBL 1(100) 2 Staphylococcus aureus ss. aureus Gentamicin Ciprofloxacin Levofloxacin Tigecycline Clindamycin Erythromycin 1(100) 1(100) 1(100) 1(100) 1(100) 1(100) Linezolid Moxifloxacin Nitrofurantoin Oxacillin Quinupristin/Dalfopristin Rifampin 1(100) 1(100) 1(100) 1(100) 1(100) 1(100) Tetracycline ESBL 1(100) 1(100)
55.
55 3 Staphylococcus hominis ss. hominis Tigecycline
Tigecycline Nitrofurantoin Quinupristin/Dalfopristin Rifampin Tetracycline 1(100) 1(100) 1(100) 1(100) 1(100) 1(100) Vancomycin ESBL 1(100) 1(100) 22. INFECTION CENTRE LANTAI 1 Tabel 23. Distribusi bakteri berdasarkan jenis spesimen No Bakteri/spesimen sputum Jumlah 1 Acinetobacter baumannii 1 1 1 Acinetobacter baumannii
56.
56 No Bakteri /Spesimen Antibiotik Resisten (%R) 1 Acinetobacter baumannii Ampicillin/Sulbactam
Piperacillin/Tazobactam Cefazolin Ceftazidime Ceftriaxone Cefepime 1(100) 1(100) 1(100) 1(100) 1(100) 1(100) Meropenem Ciprofloxacin Tigecycline 1(100) 1(100) 1(100) No Bakteri /Spesimen Antibiotik Intermediate (% ) 1 Acinetobacter baumannii Gentamicin 1(100) No Bakteri /Spesimen Antibiotik Sensitif (%S) 1 Acinetobacter baumannii Gentamicin ESBL 1(100) 1(100) 23. PALEM ATAS Tabel 26. Distribusi bakteri berdasarkan jenis spesimen No Bakteri/spesimen pus Jumlah 1 Staphylococcus haemolyticus 1 1 2 Sphingomonas paucimobilis 1 1
57.
57 No Bakteri /Spesimen Antibiotik Resisten (%R) 1 Staphylococcus haemolyticus Gentamicin
Ciprofloxacin Levofloxacin Trimethoprim/Sulfamet hoxazole Clindamycin Erythromycin 1(100) 1(100) 1(100) 1(100) 1(100) 1(100) Moxifloxacin Oxacillin Tetracycline 1(100) 1(100) 1(100) 2 Sphingomonas paucimobilis Piperacillin/Tazobactam Cefazolin Ceftazidime Ceftriaxone Cefepime Aztreonam 1(100) 1(100) 1(100) 1(100) 1(100) 1(100) Meropenem Gentamicin Ciprofloxacin Trimethoprim/Sulfamethoxazole 1(100) 1(100) 1(100) 1(100) 1 1 Staphylococcus haemolyticus Sphingomonas paucimobilis
58.
58 No Bakteri /Spesimen
Antibiotik Sensitif (%S) 1 Staphylococcus haemolyticus Tigecycline Linezolid Nitrofurantoin Quinupristin/Dalfopristin Rifampin Vancomycin 1(100) 1(100) 1(100) 1(100) 1(100) 1(100) ESBL 1(100) 2 Sphingomonas paucimobilis Amikacin Tigecycline ESBL 1(100) 1(100) 1(100)
59.
59 24. POLI PARU Tabel
27. Distribusi bakteri berdasarkan jenis spesimen No Bakteri/spesimen sputum Jumlah 1 Klebsiella pneumoniae ss. pneumoniae 1 1 No Bakteri /Spesimen Antibiotik Resisten (%R) 1 Klebsiella pneumoniae ss. pneumoniae Ampicillin 1(100) 1 Klebsiella pneumoniae ss. pneumoniae
60.
60 No Bakteri /Spesimen
Antibiotik Intermediate (% ) 1 Acinetobacter baumannii Nitrofurantoin 1(100) No Bakteri /Spesimen Antibiotik Sensitif (%S) 1 Acinetobacter baumannii Ampicillin/Sulbactam Piperacillin/Tazobactam Ceftazidime Ceftriaxone Cefepime Aztreonam 1(100) 1(100) 1(100) 1(100) 1(100) 1(100) Meropenem Amikacin Gentamicin Ciprofloxacin Tigecycline ESBL 1(100) 1(100) 1(100) 1(100) 1(100) 1(100)
61.
61 25. PCC Tabel 28.
Distribusi bakteri berdasarkan jenis spesimen No Bakteri/spesimen sputum tinja pus Jumlah 1 Acinetobacter baumannii 1 1 2 Enterobacter cloacae 1 1 3 Enterococcus faecalis 1 1 4 Enterococcus faecium 1 1 5 Staphylococcus aureus ss. aureus 1 1 1 1 1 1 1 Acinetobacter baumannii Enterobacter cloacae Enterococcus faecalis Enterococcus faecium Staphylococcus aureus ss. aureus
62.
62 No Bakteri /Spesimen Antibiotik Resisten (%R) 1 Acinetobacter baumannii Cefazolin
Ceftriaxone 1(100) 1(100) 2 Enterobacter cloacae Cefazolin Tigecycline 1(100) 1(100) 3 Enterococcus faecalis Ciprofloxacin Levofloxacin Erythromycin Quinupristin/Dalfopristin 1(100) 1(100) 1(100) 1(100) 4 Enterococcus faecium Quinupristin/Dalfopristin 1(100) 5 Staphylococcus aureus ss. aureus Tetracycline 1(100) No Bakteri /Spesimen Antibiotik Intermediate (% ) 1 Enterococcus faecalis Linezolid 1(100)
63.
63 No Bakteri /Spesimen
Antibiotik Sensitif (%S) 1 Acinetobacter baumannii Ampicillin/Sulbactam Piperacillin/Tazobactam Ceftazidime Cefepime Meropenem Amikacin 1(100) 1(100) 1(100) 1(100) 1(100) 1(100) Gentamicin Ciprofloxacin Tigecycline ESBL 1(100) 1(100) 1(100) 1(100) 2 Enterobacter cloacae Ampicillin/Sulbactam Piperacillin/Tazobactam Ceftazidime Ceftriaxone Cefepime Aztreonam 1(100) 1(100) 1(100) 1(100) 1(100) 1(100) Meropenem Amikacin Gentamicin Ciprofloxacin ESBL 1(100) 1(100) 1(100) 1(100) 1(100) 3 Enterococcus faecalis Tigecycline Nitrofurantoin Tetracycline Vancomycin Gentamicin-High Streptomycin-High 1(100) 1(100) 1(100) 1(100) 1(100) 1(100) ESBL 1(100) 4 Enterococcus faecium Ampicillin Ciprofloxacin Levofloxacin Tigecycline Erythromycin Linezolid 1(100) 1(100) 1(100) 1(100) 1(100) 1(100) Nitrofurantoin Tetracycline Vancomycin Gentamicin-High Streptomycin-High ESBL 1(100) 1(100) 1(100) 1(100) 1(100) 1(100) 5 Staphylococcus aureus ss. Aureus Gentamicin Ciprofloxacin Levofloxacin Tigecycline Clindamycin Erythromycin 1(100) 1(100) 1(100) 1(100) 1(100) 1(100)
64.
64 Linezolid Moxifloxacin Nitrofurantoin
Oxacillin Quinupristin/Dalfopristin Rifampin 1(100) 1(100) 1(100) 1(100) 1(100) 1(100) Vancomycin ESBL 1(100) 1(100)
Télécharger maintenant